• Dextromethorphan Hydrobromide: Advanced NMDA Antagonist Work

  2026-05-07

  Dextromethorphan hydrobromide from APExBIO offers unmatched reproducibility and specificity in neuroprotection and excitotoxicity research. This guide details experimental workflows, troubleshooting tactics, and protocol enhancements for leveraging its NMDA receptor antagonist properties in both in vitro and in vivo neuroscience studies.

• EZ Cap™ Firefly Luciferase mRNA: Precision for mRNA Delivery

  2026-05-07

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure sets a new benchmark for sensitive, quantitative mRNA delivery and translation efficiency assays. Its advanced capping and poly(A) tail design ensure robust bioluminescent readouts, empowering both in vitro and in vivo applications with minimal troubleshooting and maximal translational impact.

• Thiothixene Drives Macrophage Efferocytosis via Arginase 1 I

  2026-05-06

  Recent research demonstrates that thiothixene, a typical antipsychotic agent, enhances continual efferocytosis in macrophages by inducing Arginase 1 through Stra6l upregulation. This finding expands the molecule's significance beyond psychotic disorder therapy, indicating potential applications in resolving chronic inflammation and tissue damage.

• Bifendate Inhibits Autophagy and Reduces Lipid Accumulation

  2026-05-06

  This study identifies bifendate as a multi-step autophagy inhibitor that attenuates oleic acid-induced lipid droplet accumulation in cultured cells. The findings offer new mechanistic insight into bifendate’s hepatoprotective effects and highlight key methodological approaches for dissecting autophagy-lipid interactions in metabolic research.

• Angiotensin II in Translational Vascular Research: Mechanism

  2026-05-05

  Explore Angiotensin II as a potent vasopressor and GPCR agonist, delving into its molecular mechanisms and unique roles in hypertension, vascular remodeling, and emerging cross-domain virology. This article offers in-depth analysis and actionable guidance for advanced vascular smooth muscle cell hypertrophy research.

• Annexin V-Cy5/DAPI Apoptosis Kit: Mechanism-Guided Assay Sel

  2026-05-05

  Explore how the Annexin V-Cy5/DAPI Apoptosis Kit enables high-fidelity, mechanism-driven apoptosis detection. This article uniquely connects core molecular insights to practical assay optimization for cell death research.

• 25-Hydroxycholesterol Drives Macrophage Immunosuppression in

  2026-05-04

  Xiao et al. (2024) reveal that tumor-associated macrophages (TAMs) accumulate 25-hydroxycholesterol (25HC), which activates the AMPK pathway via lysosomal signaling, ultimately promoting an immunosuppressive macrophage phenotype. These findings shed light on cholesterol metabolite-driven immune modulation within the tumor microenvironment and identify CH25H as a potential target to enhance cancer immunotherapy.

• Mubritinib Reveals OXPHOS Dependency in Chemoresistant AML

  2026-05-04

  Baccelli et al. (2019) identify Mubritinib (TAK 165) as a potent, ubiquinone-dependent inhibitor of mitochondrial complex I, selectively toxic to acute myeloid leukemia (AML) subtypes with oxidative phosphorylation (OXPHOS) hyperactivity. This work maps the metabolic landscape of AML and supports targeting mitochondrial metabolism in chemoresistant disease.

• Pazopanib Hydrochloride: Mechanistic Depth and Translational

  2026-05-03

  This thought-leadership article, authored by the head of scientific marketing at a leading biotech company, explores the mechanistic foundations and translational strategies for Pazopanib Hydrochloride (GW786034) as an anti-angiogenic agent in cancer research. Integrating recent systems biology advances and referencing pivotal in vitro evaluation methodologies, the article provides actionable guidance for researchers aiming to bridge preclinical insight with clinical outcomes. Distinct from conventional product summaries, this piece contextualizes APExBIO’s offering within the competitive landscape and outlines a pragmatic, future-facing research agenda.

• 10 mM dNTP Mixture: Precision DNA Synthesis for LNP Workflow

  2026-05-02

  The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture delivers unmatched accuracy and convenience for PCR, DNA sequencing, and advanced lipid nanoparticle (LNP) studies. This article dissects how APExBIO's equimolar nucleotide mix streamlines high-impact experimental workflows, bridges the latest insights from LNP trafficking research, and provides actionable troubleshooting and optimization strategies.

• RWJ 67657: Precision Inhibitor for p38 MAPK Signaling Studie

  2026-05-01

  RWJ 67657 (JNJ-3026582) delivers unmatched selectivity and dual-action control over p38α/β MAP kinase activity in inflammatory disease models. Its workflow-compatibility, data reproducibility, and structural insights enable advanced cytokine regulation and mechanistic studies.

• P2RX1 Induces Mitochondrial Apoptosis in Ph+ ALL via Ca2+/Ca

  2026-05-01

  Li et al. (2025) identify P2RX1 as a critical driver of mitochondrial apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) by modulating intracellular calcium and suppressing PI3K/Akt signaling. These findings highlight P2RX1 as a prognostic marker and potential therapeutic target to overcome tyrosine kinase inhibitor resistance in Ph+ ALL.

• Dual Luciferase Reporter Gene System: Workflow and Optimizat

  2026-04-30

  Unlock reproducible, high-throughput gene expression analysis with the Dual Luciferase Reporter Gene System. Discover how its dual-enzyme design, no-lysis workflow, and robust normalization empower transcriptional studies, exemplified by cutting-edge cancer research.

• Ibuprofen Toxicology and Biodegradation: Environmental Insig

  2026-04-30

  Jan-Roblero and Cruz-Maya's 2023 review synthesizes current evidence on ibuprofen’s role as an emerging environmental contaminant, highlighting its persistent toxicity to aquatic organisms and the challenges facing its biodegradation. Their work underscores the need for more robust removal strategies and positions bacterial bioremediation as a promising, though still developing, solution.

• Carbon-Ion Radiotherapy Induces Ferroptosis via DHODH Suppre

  2026-04-29

  Wang and Cai (2025) demonstrate that carbon-ion radiotherapy (CIRT) suppresses gastric cancer progression by inducing ferroptosis and promoting M1 macrophage polarization through downregulation of DHODH. These findings highlight a new mechanistic basis for the enhanced efficacy of CIRT over conventional radiotherapy and suggest DHODH as a potential therapeutic target.

10211 records 4/681 page Previous Next 12345 下5页 Last page